DEFINITIVE PROXY STATEMENT

Company

Celldex Therapeutics, Inc.

Filed

August 25, 2008

Period of Report

September 25, 2008

Accession Number

0001206774-08-001493

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →